[go: up one dir, main page]

PE20070795A1 - Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa - Google Patents

Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa

Info

Publication number
PE20070795A1
PE20070795A1 PE2006001275A PE2006001275A PE20070795A1 PE 20070795 A1 PE20070795 A1 PE 20070795A1 PE 2006001275 A PE2006001275 A PE 2006001275A PE 2006001275 A PE2006001275 A PE 2006001275A PE 20070795 A1 PE20070795 A1 PE 20070795A1
Authority
PE
Peru
Prior art keywords
urea
kinase inhibitors
compounds
methyl
optionally substituted
Prior art date
Application number
PE2006001275A
Other languages
English (en)
Inventor
Jolie Anne Bastian
De Blas Jesus Andres Blas
Kevin John Hudziak
Tiechao Li
De Uralde Garmendia Beatriz Lopez
Mary Margaret Mader
Michael Ray Myers
Mark Andrew Pobanz
Chuan Shih
Boyu Zhong
Dios Alfonso De
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43298635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070795(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20070795A1 publication Critical patent/PE20070795A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I), DONDE R1 ES ALQUILO(C1-C7) OPCIONALMENTE SUSTITUIDO CON HALO, ALQUILHALO(C1-C4), O CICLOALQUILO(C3-C6) OPCIONALMENTE SUSTITUIDO, O TRIMETILSILILO; R2 ES FENILO O PIRIDINILO OPCIONALMENTE SUSTITUIDO CON ALQUILO(C1-C4); Z ES UN GRUPO a) O b); X ES UN GRUPO i), ii) y iii). SON PREFERIDOS: 1-{6-[4-(2,2-DIMETIL-PENTANOIL)-PIPERAZIN-1-IL]-PIRIDIN-3-IL}-3-[5-(1-METIL-CICLOPROPIL)-2-p-TOLIL-2H-PIRAZOL-3-IL]-UREA, 1-{6-[4-(1-METIL-CICLOHEXANECARBONIL)-PIPERAZIN-1-IL]-PIRIDIN-3-IL}-3-[5-(1-METIL-CICLOPROPIL)-2-p-TOLIL-2H-PIRAZOL-3-IL]-UREA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DE CINASA p38 Y SON UTILES EN EL TRATAMIENTO DE TRASTORNOS INFLAMATORIOS, CARDIOVASCULARES Y DEL SISTEMA NERVIOSO CENTRAL
PE2006001275A 2005-10-28 2006-10-20 Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa PE20070795A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73160405P 2005-10-28 2005-10-28
EP06380151 2006-06-02
US82196306P 2006-08-10 2006-08-10

Publications (1)

Publication Number Publication Date
PE20070795A1 true PE20070795A1 (es) 2007-08-24

Family

ID=43298635

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001275A PE20070795A1 (es) 2005-10-28 2006-10-20 Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa

Country Status (19)

Country Link
US (1) US7652015B2 (es)
EP (1) EP1943243B1 (es)
KR (1) KR101004156B1 (es)
AR (1) AR056582A1 (es)
AT (1) ATE493403T1 (es)
AU (1) AU2006309044B2 (es)
BR (1) BRPI0616901A2 (es)
CA (1) CA2627673A1 (es)
DK (1) DK1943243T3 (es)
DO (1) DOP2006000234A (es)
EA (1) EA015189B1 (es)
PE (1) PE20070795A1 (es)
PL (1) PL1943243T3 (es)
PT (1) PT1943243E (es)
RS (1) RS51949B (es)
SI (1) SI1943243T1 (es)
TN (1) TNSN08191A1 (es)
TW (1) TWI325423B (es)
WO (1) WO2007053394A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
WO2011124930A1 (en) 2010-04-08 2011-10-13 Respivert Limited P38 map kinase inhibitors
JP5973426B2 (ja) 2010-06-17 2016-08-23 レスピバート・リミテツド Ｐ３８ｍａｐｋ阻害剤を含む呼吸器用製剤
US9029378B2 (en) 2011-07-26 2015-05-12 Gruenenthal Gmbh Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands
US9783556B2 (en) 2012-08-29 2017-10-10 Respivert Limited Kinase inhibitors
EP2890695A2 (en) 2012-08-29 2015-07-08 Respivert Limited Kinase inhibitors
US20150210722A1 (en) 2012-08-29 2015-07-30 Respivert Limited Kinase inhibitors
EP2925742B1 (en) 2012-11-16 2016-10-26 Respivert Limited Kinase inhibitors
DK2981535T3 (da) 2013-04-02 2021-03-01 Oxular Acquisitions Ltd Urinstofderivater, der er anvendelige som kinaseinhibitorer
EP2981534B1 (en) 2013-04-02 2017-07-19 Topivert Pharma Limited Kinase inhibitors based upon n-alkyl pyrazoles
JP6514703B2 (ja) 2013-12-20 2019-05-15 トピバート ファーマ リミテッド キナーゼインヒビターとして有用な尿素誘導体
IL280785B2 (en) 2014-03-07 2024-09-01 Biocryst Pharm Inc Human plasma kallikrein inhibitors
MA40775A (fr) 2014-10-01 2017-08-08 Respivert Ltd Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38
MA44607A (fr) 2016-04-06 2021-05-19 Oxular Acquisitions Ltd Inhibiteurs de kinase
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CN111601593B (zh) 2017-10-05 2022-04-15 弗尔康医疗公司 P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd
DK3786160T3 (da) 2017-10-27 2022-08-22 Boehringer Ingelheim Int Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer
US12059408B2 (en) 2020-08-13 2024-08-13 Boehringer Ingelheim International Gmbh Treatment of cognitive impairment associated with schizophrenia
BR112023004774A2 (pt) 2020-10-13 2023-04-25 Boehringer Ingelheim Int Processo de retrabalho

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136768A0 (en) * 1997-12-22 2001-06-14 Bayer Ag INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
DK1761520T3 (da) * 2004-06-23 2008-10-27 Lilly Co Eli Kinaseinhibitorer

Also Published As

Publication number Publication date
US7652015B2 (en) 2010-01-26
AR056582A1 (es) 2007-10-10
TWI325423B (en) 2010-06-01
SI1943243T1 (sl) 2011-04-29
KR20080053394A (ko) 2008-06-12
EA200801199A1 (ru) 2008-08-29
PT1943243E (pt) 2011-01-11
AU2006309044B2 (en) 2011-10-13
DOP2006000234A (es) 2007-05-31
EP1943243B1 (en) 2010-12-29
EP1943243A1 (en) 2008-07-16
CA2627673A1 (en) 2007-05-10
WO2007053394A1 (en) 2007-05-10
DK1943243T3 (da) 2011-03-07
PL1943243T3 (pl) 2011-05-31
US20080269244A1 (en) 2008-10-30
KR101004156B1 (ko) 2010-12-27
TW200800184A (en) 2008-01-01
ATE493403T1 (de) 2011-01-15
TNSN08191A1 (en) 2009-10-30
AU2006309044A1 (en) 2007-05-10
BRPI0616901A2 (pt) 2011-07-05
RS51949B (sr) 2012-02-29
EA015189B1 (ru) 2011-06-30

Similar Documents

Publication Publication Date Title
PE20070795A1 (es) Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa
GB0402137D0 (en) Novel compounds
GB0402143D0 (en) Novel compounds
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20071593L (no) Pyrimidinderivater
PE20130774A1 (es) Compuestos heterociclicos activadores de ampk y metodos para emplearlos
NO20070731L (no) Heterocykliske forbindelser.
NO20075273L (no) Nye forbindelser
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
AR055613A1 (es) Formas cristalinas delta y epsilon de mesilato de imatinib
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
PE20090714A1 (es) Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20081581L (no) Polymorfer av benzoatsalt av 2-[[6-[(3R)-3-amino-l-piperldinyl]-3,4-dihydro-3-metyl-2,4-diokso- 1(2H)-pyrlmidinylJmetyl)benzonitril, og fremgangsmater for anvendelse derav
PE20070004A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
WO2009065919A3 (de) Organische verbindungen
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
NO20075987L (no) Bisykliske derviater som p38-kinaseinhibitorer
WO2009065920A3 (de) Verbindungen
NO20075275L (no) Nye forbindelser
EA200601391A1 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
UY30823A1 (es) Piperidinas sustituidas que contienen una fraccion de heteroarilamida o heteroarilfenilo
NO20076345L (no) Bisykliske derivater som P38-kinaseinhibitorer
NO20071574L (no) Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed